The Publications Division of the American Chemical Society (ACS) has appointed Dr. Theresa Reineke, the University of Minnesota, Twin Cities (UMTC), as editor in chief of Bioconjugate Chemistry.
Reineke has held several roles across the ACS journal portfolio, most notably as a founding associate editor with ACS Macro Letters, where she was on the editorial team for 10 years. Additional editorial advisory boards she has served on include Bioconjugate Chemistry, Biomacromolecules and ACS Applied Polymer Materials. She is also an active member of several ACS technical divisions.
Her research interests include studying fundamental monomer and polymer synthesis and degradation, exploring structural ordering and directing molecular interactions of macromolecules with biological systems, and understanding fundamental physicochemical and biological properties of macromolecular materials. The Reineke research group focuses on enabling fundamental chemistry and applied technology advancements of macromolecules for drug delivery, imaging, gene and cell therapy, genome editing and sustainability. Her group is working on several projects in drug/nucleic acid delivery and sustainability.
Reineke is a Prager chair in macromolecular science and a Distinguished McKnight university professor in the department of chemistry at UMTC, where she also holds graduate faculty appointments in the departments of chemical engineering/materials science and pharmaceutics. She was named a 2022 ACS Arthur C. Cope scholar and has received several other prestigious honors, including the 2018 DuPont Nutrition & Health Science Excellence Medal, a National Institutes of Health Director’s New Innovator Award, a National Science Foundation CAREER Award, and the 2017 Carl S. Marvel Award for Creative Polymer Chemistry from the ACS division of polymer chemistry, along with numerous junior investigator awards from the Alfred P. Sloan Foundation, Camille & Henry Dreyfus Foundation and Arnold & Mabel Beckman Foundation.
Reineke will officially assume her role on January 1, 2023. Bioconjugate Chemistry invites original contributions on all research at the interface between synthetic and biological materials. The mission of the journal is to communicate advances in a broad range of fields, including therapeutic delivery, imaging, bionanotechnology and synthetic biology. Bioconjugate Chemistry is intended to provide a forum for presentation of research relevant to all aspects of bioconjugates, including the preparation, properties and applications of biomolecular conjugates.
Click here to read the original press release.
